news and events.
October 11, 2023
💥Amalus Therapeutics Finalist for OBN Awards
Amalus Therapeutics is a finalist for the BioSeed One-to-Watch category for the Oxford Business Network (OBN UK) 2023 Awards!
Showcasing impressive innovation and achievement, an external panel of experienced judges will now assess our entry, and the winners will be announced live at The Royal Lancaster in London on November 22nd.
Find out more and join the celebration at www.obn-awards.com!
August 31, 2023
🔬 Exciting News! Amalus Therapeutics Selected for BII Venture Lab 🚀
We are elated to announce that Amalus Therapeutics has been selected to join the BioInnovation Institute Venture Lab 5 cohort! This achievement marks a significant milestone in our journey towards revolutionizing fibroblast-targeted treatments. It is also the culmination of six months of intense dedication, passing each selection round with excitement and determination.
The financial support from the BII will catalyze our efforts to drive our technology development, and the training and mentoring in the Venture Lab program will propel us closer to becoming successful biotech founders. We're eager to learn from industry experts and from fellow entrepreneurs.
Our selection for the BII Venture Lab is a testament to the tireless dedication and innovative spirit that defines Amalus Therapeutics.
We look forward to sharing the upcoming milestones and successes with all of you as we embark on this exciting chapter!
Further reading: announcement of the BioInnovation Institute.